Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Keytruda
Keytruda
Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’
BioPharma Dive
Tue, 02/21/23 - 11:05 am
Big Pharma
patents
patent cliff
biosimilars
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Opdivo
Merck targets BMS' stomach cancer head start with Keytruda win, but past failure casts shadow
Fierce Pharma
Thu, 02/16/23 - 04:54 pm
Merck
Keytruda
clinical trials
stomach cancer
After several flops, Merck exec stands by aggressive Keytruda prostate cancer program
Fierce Biotech
Thu, 02/16/23 - 11:06 am
Merck
Keytruda
prostate cancer
The end of the Humira era
EP Vantage
Mon, 01/30/23 - 10:46 am
AbbVie
Humira
patents
biosimilars
Merck
Keytruda
A Hit and a Miss for Merck’s Keytruda
BioSpace
Wed, 01/25/23 - 10:42 am
Merck
Keytruda
prostate cancer
biliary tract cancer
Immuno-oncology goes subcutaneous
EP Vantage
Wed, 01/25/23 - 10:18 am
immuno-oncology
oncology
subcutaneous drug delivery
Keytruda
Merck
Tecentriq
Roche
Chasing Roche, Merck talks up subcutaneous Keytruda ahead of phase 3 data drop
Fierce Pharma
Mon, 01/16/23 - 11:16 am
Merck
Keytruda
Roche
cancer
oncology
BioXcel, keeping cards close to its chest, teases phase 2 Keytruda combination trial data drop
Fierce Biotech
Wed, 01/11/23 - 11:00 am
BioXcel Therapeutics
clinical trials
Keytruda
BXCL701
prostate cancer
Merck Highlights Growth Strategy at J.P. Morgan
BioSpace
Tue, 01/10/23 - 06:48 pm
Merck
JPMHC 2023
Keytruda
vaccines
M&A
OncoC4 doses first participant in ovarian cancer therapy trial
Clinical Trials Arena
Mon, 01/2/23 - 06:33 pm
OncoC4
clinical trials
ONC-392
Merck
Keytruda
ovarian cancer
platinum-resistant ovarian cancer
Moderna, Merck & Co. mRNA cancer vaccine slashes melanoma recurrence in Keytruda combo trial
Fierce Biotech
Tue, 12/13/22 - 10:35 am
Merck
Moderna Therapeutics
MRNA
cancer immunotherapy
Keytruda
melanoma
Mirati to focus adagrasib/Keytruda study in low PDL1 lung cancer patients
Yahoo/Reuters
Tue, 12/6/22 - 10:21 am
Mirati Therapeutics
adagrasib
Merck
Keytruda
metastatic lung cancer
lung cancer
GSK unveils Keytruda head-to-head data in lung cancer—and they look good at first glance
Fierce Pharma
Wed, 11/30/22 - 07:58 pm
GSK
Merck
Jemperli
Keytruda
clinical trials
non-small cell lung cancer
Merck scores another win for Keytruda, this time in HER2-negative cancer
Endpoints
Tue, 11/22/22 - 04:39 pm
Merck
Keytruda
clinical trials
adenocarcinoma
Is Merck Too Dependent on Keytruda?
Motley Fool
Wed, 11/9/22 - 10:50 am
Merck
Keytruda
Catching up with Keytruda, Regeneron scores frontline NSCLC approval for Libtayo/chemo combo
Endpoints
Wed, 11/9/22 - 10:38 am
Regeneron
Libtayo
non-small cell lung cancer
Keytruda
Merck
Gilead, Arcus slim phase 3 TIGIT trial to take on king Keytruda
Fierce Biotech
Thu, 11/3/22 - 11:10 am
Gilead Sciences
ARCUS
clinical trials
Merck
Keytruda
domvanalimab
zimberelimab
non-small cell lung cancer
Bristol Myers spells out Opdivo win in melanoma — how does it stack up against Keytruda?
Endpoints
Thu, 10/20/22 - 10:41 am
Bristol Myers Squibb
Opdivo
melanoma
Merck
Keytruda
Kineta, Merck Strike Deal to Pair Anti-VISTA Antibody with Keytruda
BioSpace
Mon, 10/17/22 - 10:51 am
Kineta
Merck
Keytruda
anti-VISTA
monoclonal antibodies
solid tumors
OncoSec sheds 45% of staff to fund IL-12 drug through Keytruda combo trial
Fierce Biotech
Wed, 10/5/22 - 10:31 am
OncoSec Medical
melanoma
clinical trials
Keytruda
layoffs
Tavo
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »